Dr. Angus Sinclair, PhDExecutive Vice President, Research at IGM BiosciencesSpeaker
Profile
Dr. Sinclair joined IGM Biosciences in 2018 and is our Executive Vice President of Research. Prior to joining IGM, Dr. Sinclair served as Senior Director, Oncology Research at Northern Biologics, a biotechnology company, from 2015 to 2018. He also previously served in various scientific and leadership positions at Amgen, including most recently as Scientific Director, Oncology Research, from 2011 to 2015. Dr. Sinclair received a B.Sc. in Molecular Biology from the University of Edinburgh and a Ph.D. in Hematology/Molecular Biology from the National Institute for Medical Research/University College London.
Agenda Sessions
Therapeutic Potential of IgM-based Bispecific Antibodies for the Treatment of Refractory Autoimmune Disease Patients
, 4:45pmView Session